Evidence map›Paper›PMID 37792253›Full record

ReviewHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2023

The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation.

Alessandro Maloberti, Alessandro Mengozzi, Elisa Russo, Arrigo Francesco Giuseppe Cicero, Fabio Angeli, Enrico Agabiti Rosei, Carlo Maria Barbagallo, Bruno Bernardino, Michele Bombelli, Federica Cappelli and 41 more

Open access · hybridAbstract readReview
In one paragraph

Review in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Comprehensive Review on Febuxostat for Hyperuricemia with Gout: Insights from Current Practice and Clinical Trials.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 20 institutions in 2 countries.

Alessandro MalobertiCardiology IV, "A.De Gasperis" Department, Ospedale Niguarda Ca' Granda, Milan, Italy.
Alessandro MengozziDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Elisa RussoDepartment of Internal Medicine, University of Genoa and IRCCS Ospedale Policlinico SanMartino, Genoa, Italy.
Arrigo Francesco Giuseppe CiceroHypertension and Cardiovascular Risk Research Group, Department of Medical and Surgical Science, Alma Mater Studiorum University of Bologna, Bologna, Italy. arrigo.cicero@unibo.it.ORCID http://orcid.org/0000-0002-4367-3884
Fabio AngeliDepartment of Medicine and Surgery, University of Insubria, Varese, Italy.
Enrico Agabiti RoseiDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Carlo Maria BarbagalloBiomedical Department of Internal Medicine and Specialistics, University of Palermo, Palermo, Italy.
Bruno BernardinoDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Michele BombelliSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Federica CappelliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Edoardo CasigliaDepartment of Medicine, University of Padua, Padua, Italy.
Rosario CianciDepartment of Translational and Precision Medicine, University of Rome La Sapienza, Rome, Italy.
Michele CiccarelliDepartment of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Massimo CirilloDepartment of Public Health, ''Federico II'' University of Naples, Naples, Italy.
Pietro CirilloNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, ''Aldo Moro'' University of Bari, Bari, Italy.
Giovambattista DesideriDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Lanfranco D'EliaDepartment of Clinical Medicine and Surgery, ''Federico II'' University of Naples, Naples, Italy.
Raffaella Dell'OroSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Rita FacchettiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Claudio FerriDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Ferruccio GallettiDepartment of Clinical Medicine and Surgery, ''Federico II'' University of Naples, Naples, Italy.
Cristina GiannattasioCardiology IV, "A.De Gasperis" Department, Ospedale Niguarda Ca' Granda, Milan, Italy.
Loreto GesualdoNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, ''Aldo Moro'' University of Bari, Bari, Italy.
Guido IaccarinoDepartment of Advanced Biomedical Sciences, ''Federico II'' University of Naples, Naples, Italy.
Luciano LippaItalian Society of General Medicine (SIMG), Avezzano, L'Aquila, Italy.
Francesca MallamaciReggio Cal Unit, Clinical Epidemiology of Renal Diseases and Hypertension, CNR-IFC, Reggio Calabria, Italy.
Stefano MasiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Maria MasulliDepartment of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Alberto MazzaDepartment of Internal Medicine, Santa Maria della Misericordia General Hospital, AULSS 5 Polesana, Rovigo, Italy.
Maria Lorenza MuiesanDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Pietro NazzaroDepartment of Medical Basic Sciences, Neurosciences and Sense Organs, University of Bari Medical School, Bari, Italy.
Gianfranco ParatiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Paolo PalatiniDepartment of Medicine, University of Padua, Padua, Italy.
Paolo PaulettoMedicina Interna I, Ca' Foncello University Hospital, Treviso, Italy.
Roberto PontremoliDepartment of Internal Medicine, University of Genoa and IRCCS Ospedale Policlinico SanMartino, Genoa, Italy.
Nicola Riccardo PuglieseDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Fosca Quarti-TrevanoSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Marcello RattazziDepartment of Medicine, University of Padua, Padua, Italy.
Gianpaolo ReboldiDepartment of Medical and Surgical Science, University of Perugia, 06100, Perugia, Italy.
Giulia RivasiDepartment of Geriatric and Intensive Care Medicine, Careggi Hospital and University of Florence, Florence, Italy.
Massimo SalvettiDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Valerie TikhonoffDepartment of Medicine, University of Padua, Padua, Italy.
Giuliano TocciHypertension Unit, Division of Cardiology, Sant'Andrea Hospital, Rome, Italy.
Andrea UngarDepartment of Geriatric and Intensive Care Medicine, Careggi Hospital and University of Florence, Florence, Italy.
Paolo VerdecchiaHospital S. Maria della Misericordia, Perugia, Italy.
Francesca ViazziDepartment of Internal Medicine, University of Genoa and IRCCS Ospedale Policlinico SanMartino, Genoa, Italy.
Massimo VolpeHypertension Unit, Division of Cardiology, Sant'Andrea Hospital, Rome, Italy.
Agostino VirdisDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Guido GrassiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Claudio BorghiHypertension and Cardiovascular Risk Research Group, Department of Medical and Surgical Science, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)
University of Pisa · ITUniversity of Padua · ITAzienda Ospedaliera San Gerardo · ITOspedale Policlinico San Martino · ITUniversity of Bari Aldo Moro · ITUniversity of Brescia · ITUniversity of L'Aquila · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCTO Andrea Alesini · ITUniversity of Bologna · ITUniversity of Florence · ITUniversity of Naples Federico II · ITUniversity of Salerno · ITCa' Foncello Hospital · ITFederico II University Hospital · ITIRCCS Istituto Auxologico Italiano · ITIstituto di Fisiologia Clinica · ITOspedale Santa Maria della Misericordia di Rovigo · ITSapienza University of Rome · ITSocietà Italiana di Medicina Generale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality but also acute coronary syndrome, stroke and heart failure. Similarly, also many papers have been published on the association between UA and kidney function, while less is known on the role of UA in metabolic derangement and, particularly, in metabolic syndrome. Despite the substantial number of publications on the topic, there are still some elements of doubt: (1) the better cut-off to be used to refine CV risk (also called CV cut-off); (2) the needing for a correction of UA values for kidney function; and (3) the better definition of its role in metabolic syndrome: is UA simply a marker, a bystander or a key pathological element of metabolic dysregulation?. The Uric acid Right for heArt Health (URRAH) project was designed by the Working Group on uric acid and CV risk of the Italian Society of Hypertension to answer the first question. After the first papers that individuates specific cut-off for different CV disease, subsequent articles have been published responding to the other relevant questions. This review will summarise most of the results obtained so far from the URRAH research project.

Indexed as

Acute Coronary SyndromeHyperuricemiaKidney DiseasesMetabolic SyndromeHumansRisk FactorsUric AcidUric AcidCardiovascular diseasesKidney functionMetabolic derangementMetabolic syndromeUric acidURRAH

Identifiers

PMID37792253
PMCPMC10600296
OpenAlexW4387326833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.